NVO Q3 2016 Earnings Report — Novo Nordisk A/S Revenue & Financial Results | Market Cap Arena

Novo Nordisk A/SNVO

Q3 2016 Earnings

Reported September 29, 2016

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q3 2016	Q2 2016	Q3 2015	QoQ Change	YoY Change
Revenue	$4.3B	$4.3B	—	0.3%	—
Op. Income	$1.9B	$2.0B	—	-0.6%	—
Gross Margin	85.5%	85.3%	—	0.3pp	—
Net Margin	35.6%	36.3%	—	-0.7pp	—
EPS (Diluted)	$0.30	$0.31	—	-1.0%	—
Free Cash Flow	$2.0B	$2.0B	—	-1.2%	—

Revenue Flow

Item	Amount
REVENUE	$4.3B
Cost of Revenue	$625M
GROSS PROFIT	$3.7B
R&D Expenses	$543M
Selling & Marketing	$1.1B
General & Administrative	$159M
SG&A Expenses	$1.2B
Other Expenses	-$32M
Operating Expenses	$1.7B
Cost & Expenses	$2.4B
OPERATING INCOME	$1.9B
Interest Income	$0
Interest Expense	$19M
Other Income/Expenses	-$19M
INCOME BEFORE TAX	$1.9B
Income Tax Expense	$392M
Net Income from Continuing Ops	$1.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.5B
D&A	$115M
EBIT	$1.9B
EBITDA	$2.1B
EPS	$0
EPS Diluted	$0

Income Statement

Item	Amount
REVENUE	$4.3B
Cost of Revenue	$625M
GROSS PROFIT	$3.7B
R&D Expenses	$543M
Selling & Marketing	$1.1B
General & Administrative	$159M
SG&A Expenses	$1.2B
Other Expenses	-$32M
Operating Expenses	$1.7B
Cost & Expenses	$2.4B
OPERATING INCOME	$1.9B
Interest Income	$0
Interest Expense	$19M
Other Income/Expenses	-$19M
INCOME BEFORE TAX	$1.9B
Income Tax Expense	$392M
Net Income from Continuing Ops	$1.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.5B
D&A	$115M
EBIT	$1.9B
EBITDA	$2.1B
EPS	$0
EPS Diluted	$0

Cash Flow Statement

Item	Amount
Net Income	$1.5B
Depreciation & Amortization	$115M
Stock-Based Compensation	$0
Deferred Income Tax	$392M
Other Non-Cash Items	$190M
Change in Working Capital	-$377M
OPERATING CASH FLOW	$2.4B
Capital Expenditure	-$409M
Acquisitions (Net)	$129M
Purchases of Investments	-$16M
Sales/Maturities of Investments	$4M
Other Investing Activities	-$128M
NET CASH FROM INVESTING	-$420M
Net Debt Issuance	$0
Common Stock Repurchased	-$565M
Common Dividends Paid	-$1.2B
Other Financing Activities	$0
NET CASH FROM FINANCING	-$1.8B
FREE CASH FLOW	$2.0B
Net Change in Cash	$207M

Balance Sheet

Item	Amount
Cash & Equivalents	$2.3B
Short-Term Investments	$320M
Net Receivables	$3.2B
Inventory	$2.2B
Other Current Assets	$708M
TOTAL CURRENT ASSETS	$8.1B
PP&E (Net)	$4.4B
Goodwill	$0
Intangible Assets	$447M
Long-Term Investments	$314M
Tax Assets	$422M
Other Non-Current Assets	$0
TOTAL NON-CURRENT ASSETS	$5.6B
TOTAL ASSETS	$13.7B
Account Payables	$700M
Short-Term Debt	$72M
Deferred Revenue	$3.6B
Other Current Liabilities	$2.1B
TOTAL CURRENT LIABILITIES	$6.5B
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$2M
Other Non-Current Liabilities	$692M
TOTAL NON-CURRENT LIABILITIES	$694M
TOTAL LIABILITIES	$7.2B
Common Stock	$80M
Additional Paid-In Capital	$0
Retained Earnings	$6.4B
Treasury Stock	-$941.5K
Accum. Other Comp. Income	-$37M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$6.5B
Minority Interest	$0
TOTAL EQUITY	$6.5B
TOTAL LIABILITIES & EQUITY	$13.7B
Total Debt	$72M
Net Debt	-$2.2B